Current
Industry
Industries
Health Sciences and Wellness

Anthestos Pharmaceuticals

Health Sciences and Wellness

Anthestos Pharmaceuticals is a newly founded R&D intensive pharmaceutical company aiming to develop innovative medicines for serious, incurable chronic diseases, with a focus on skin disorders. Anthestos Pharmaceuticals is dedicated to leading the development of novel treatments that significantly improve the quality of life for millions suffering from psoriasis and other debilitating conditions worldwide.

Anthestos Pharmaceuticals has currently pioneered a novel small molecule, a retinoic acid - spermine conjugate abbreviated as RASP produced in its crystal form (crRASP), now advancing through preclinical trials. The data obtained so far show a breakthrough safety and efficacy of crRASP in psoriasis. Preclinical research has also indicated the potential of crRASP in acne, aging, skin cancer and autoimmune diseases. Our primary business goal is currently to develop crRASP as an efficient treatment of psoriasis by concluding the preclinical trials phase and initiating the clinical development program.

Anthestos Pharmaceuticals aims to finance its crRASP development program through strategic partnerships, investments and SME funding schemes.

Current
Industry
Industries
Health Sciences and Wellness